The trademark BIOINTRON was filed by Biointron Biological Inc., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on April 10, 2023, and received one opposition filed on May 11, 2023 by TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH on Likelihood of confusion. the opponent was represented by metaCom LEGAL and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 11, 2023
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 30, 2024.
The Opposition with reference B 003195697 was rejected according to Article 8(1)(b) EUTMR with decision issued on May 15, 2024 by the EUIPO. The Appeal with reference B R1138/2024-1 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on January 19, 2025 by the EUIPO.
Goods And Services
The mark was filed in class 1 with following description of goods:
Animal albumen [raw material]
Enzyme preparations for industrial purposes
Proteins for use in manufacture
Protein for industrial use
Stem cells other than for medical or veterinary purposes
Diagnostic preparations, other than for medical or veterinary purposes
Biological preparations, other than for medical or veterinary purposes
Chemical reagents for use in diagnostic tests, other than for medical or veterinary use
Enzyme preparations for the food industry
Proteins for the food industry.
The mark was filed in class 5 with following description of goods:
Biological preparations for medical purposes
Diagnostic preparations for medical purposes
Enzyme preparations for medical purposes
Amino acids for medical purposes
Biological preparations for the treatment of cancer
Reagents for analytical purposes [for medical purposes]
Diagnostic preparations for medical or veterinary purposes
Stem cells for medical purposes
Chemical reagents for medical or veterinary purposes
Albuminous foodstuffs for medical purposes.
The mark was filed in class 42 with following description of goods:
Quality testing
Research and development of new products for others
Structural and functional analysis of genomes
Stem cell research services
Pharmaceutical research and development services
Conducting early evaluations in the field of new pharmaceuticals
Development of pharmaceutical preparations and medicines
Pharmaceutical research services
Biological research and analysis
Research and development services in the field of antibodies.